Market Tracker

03/28 7:49am ET

Halozyme Therapeutics Inc (NASDAQ:HALO)

14.27
Delayed Data
As of Mar 27
 +0.74 / +5.47%
Today’s Change
7.70
Today|||52-Week Range
15.20
+44.43%
Year-to-Date
No recent news for Halozyme Therapeutics Inc.

Today’s Trading

Previous close13.53
Today’s open13.29
Day’s range13.06 - 14.37
Volume1,239,313
Average volume (3 months)1,776,587
Market cap$1.9B
Dividend yield--
Data as of 03/27/2017

Growth & Valuation

Earnings growth (last year)-224.00%
Earnings growth (this year)-19.93%
Earnings growth (next 5 years)+7.12%
Revenue growth (last year)+8.61%
P/E ratioNM
Price/Sales8.62
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RDUSRadius Health Inc+0.78+2.04%
ONCESpark Therapeutics I...+0.22+0.42%
AVXSAveXis Inc+1.38+1.84%
JUNOJuno Therapeutics In...+0.65+3.22%
Data as of 03/27/2017

Financials

Next reporting dateMay 8, 2017
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$146.7M
Annual profit (last year)-$103.0M
Net profit margin-70.23%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts